Identifying sleep apnea biomarkers
Part of Brain & nervous system, Lungs & breathing clinical trials.
This study compares blood samples from people with moderate-to-severe sleep apnea and those without sleep apnea to find markers that could help diagnose or treat the condition. Half of those with sleep apnea will start CPAP therapy right away, while others wait before starting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 65.
- Either have moderate-to-severe sleep apnea (15+ breathing pauses per hour) OR no sleep apnea (fewer than 5 pauses per hour).
- Willing to give blood samples and complete study procedures.
- If you have sleep apnea, willing to use a CPAP machine and be randomly assigned to start treatment now or later.
- Not have severe heart, kidney, liver, or lung disease, active cancer, or chronic inflammation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain markers in sleep apnea patients can predict how well they will stick with CPAP (a mask that helps you breathe at night). If you're newly diagnosed and about to start CPAP, this could help personalize your care.
This trial is studying tiny molecules in the blood (called microRNAs) to see if they can help diagnose or monitor obstructive sleep apnea. It compares people with moderate to severe sleep apnea who are starting PAP therapy with people who do not have sleep apnea.
This study looks for a biological marker of severe daytime sleepiness in people with severe obstructive sleep apnea who haven't started breathing machine treatment yet. It may help doctors better understand and treat sleepiness in the future.
This study helps doctors understand how to better adjust sleep apnea breathing machines by measuring your airway. You'll have a simple breathing test and overnight sleep study to help improve treatment.
This study is improving how doctors classify obstructive sleep apnea (a condition where your breathing stops and starts during sleep). It focuses on sleepiness and heart-related risks to help guide treatment. If you are 40 or older and have untreated OSA, you may be able to join.
This study tests a sleep apnea treatment approach and looks at how it may affect your body’s metabolism. You may be eligible if you’re an adult with sleep apnea and meet health and medication rules, and possibly if you already use a PAP machine regularly.
Hear when a new Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.